JohnsonD.W., ClarkC., IsbelN.M., HawleyC.M., BellerE., CassA.The HONEYPOT study protocol: a randomized controlled trial of exit-site application of Medihoney Antibacterial Wound Gel for the prevention of catheter-associated infections in peritoneal dialysis patients.Perit Dial Int2009; 29: 303–9.
2.
JassalS.V., LokC.E.A randomized controlled trial comparing mupirocin versus Polysporin Triple for the prevention of catheter-related infections in peritoneal dialysis patients (The MP3 Study).Perit Dial Int2008; 28: 67–72.
3.
MujaisS.Microbiology and outcomes of peritonitis in North America.Kidney Int Suppl2006; 103: S55–62.
ChalmersI., AltmanD.G.How can medical journals help prevent poor medical research? Some opportunities presented by electronic publishing.Lancet1999; 353: 490–3.
6.
Al MarzoukiS., RobertsI., EvansS., MarshallT.Selective reporting in clinical trials: analysis of trial protocols accepted by The Lancet.Lancet2008; 372: 201.
7.
GreeneT., BeckG.J., GassmanJ.J., GotchF.A., KusekJ.W., LeveyA.S.Design and statistical issues of the Hemodialysis (HEMO) Study.Control Clin Trials2000; 21: 502–25.
8.
WannerC., KraneV., MarzW., OlschewskiM., MannJ.F., RufG.Atorvastatin in patients with type 2 diabetes mellitus undergoing hemodialysis.N Engl J Med2005; 353: 238–48.
9.
HortonR.Pardonable revisions and protocol reviews.Lancet1997; 349: 6.
10.
McNameeD., JamesA., KleinertS.Protocol review at The Lancet.Lancet2008; 372: 189–90.
11.
HawkeyC.J.Journals should see original protocols for clinical trials.BMJ2001; 323: 1309.
